Cargando…
Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
Autores principales: | Meduri, Gianfranco Umberto, Rochwerg, Bram, Annane, Djillali, Pastores, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968582/ https://www.ncbi.nlm.nih.gov/pubmed/29793515 http://dx.doi.org/10.1186/s13054-018-2007-z |
Ejemplares similares
-
Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment
por: Umberto Meduri, Gianfranco, et al.
Publicado: (2011) -
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
por: Villar, Jesús, et al.
Publicado: (2020) -
Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2020) -
Corticosteroids for community-acquired pneumonia: time to act!
por: Annane, Djillali, et al.
Publicado: (2008) -
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis
por: Pitre, Tyler, et al.
Publicado: (2023)